{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-25-037426","form_type":"8-K","ticker":"AGL","cik":"0001831097","company_name":"agilon health, inc.","filed_at":"2025-08-04T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.204812+00:00","generated_at":"2026-05-17T21:34:20.220314+00:00","sec_items":["2.02","5.02","5.03","7.01","9.01"],"event_type":"leadership","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"CEO Sell resigns; agilon posts $104M Q2 net loss, suspends 2025 guidance","bullets":["Steven Sell resigned as CEO/President and Board director effective July 29; Board reduced to seven directors.","Executive Chairman Ron Williams appointed; Office of the Chairman formed to oversee interim operations.","Q2 total revenue $1.39B (-6% YoY); net loss $104M vs $31M loss in Q2 2024.","Medical margin negative $53M vs positive $106M; adjusted EBITDA loss $83M vs $3M loss.","Full-year 2025 guidance suspended due to leadership change and market headwinds."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-25-037426","json":"https://secwatch.observer/filing/0001628280-25-037426.json","markdown":"https://secwatch.observer/filing/0001628280-25-037426.md","text":"https://secwatch.observer/filing/0001628280-25-037426.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1831097/000162828025037426/0001628280-25-037426-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1831097/000162828025037426/agl-20250729.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T21:34:20.220314+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"095871d3b7b039732da37396084a0cd6884aa93b","claim":"agilon health, inc.: Amended and restated the bylaws to adopt amendments relating to officer positions and technical updates reflecting Delaware law changes (effective 2025-07-29).","evidence_excerpt":"On July 29, 2025, the Board amended and restated the by-laws of the Company (as amended, the “Amended and Restated By-laws”).","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1831097/000162828025037426/0001628280-25-037426-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"bylaw amendment"},{"label":"Effective","value":"2025-07-29"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}